References
- Klein H, Anstee D. Mollison’s blood transfusion in clinical medicine. Malden, MA: Blackwell Publishing, 2005.
- van Buren NL. Autoimmune hemolytic anemias. In: Hillyer CD, Shaz BH, Abshire TC, Zimring JC, eds. Transfusion medicine and hemostasis: clinical and laboratory aspects. Amsterdam: Elsevier, 2009:1–1019.
- Daniels G. Human blood groups. Oxford: Blackwell Science, 2002.
- Cooling L. An update on the I blood group system. Immunohematology 2019;35:85–90.
- Berentsen S, Tjønnfjord GE. Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. Blood Rev 2012;26107–15.
- Rosenfield R, Schroeder R, Ballard R, van der Hart M, Moes M, van Loghem J. Erythrocytic antigenic determinants characteristic of H, I in the presence of H (IH), or H in the absence of I (H(-I)). Vox Sang 1964;9:415–9.
- Berentsen S, Małecka A, Randen U, Tjønnfjord GE. Cold agglutinin disease: where do we stand, and where are we going? Clin Adv Hematol Oncol 2020;18:35–44.
- Berentsen S, D’Sa S, Randen U, Malecka A, Vos JMI. Cold agglutinin disease: improved understanding of pathogenesis helps define targets for therapy. Hemato 2022;3:574–94.
- Arndt P, Garratty G, Haverty D, McGrath C, Tobias P, Larison J. Clinically significant anti-HI in two patients with greatly increased I antigen on their red cells (abstract). Blood 1997;90(Suppl 1):472a.
- Campbell S, Shirey R, King K, Ness P. An acute hemolytic transfusion reaction due to anti-IH in a patient with sickle cell disease. Transfusion 2000;40:828–31.
- Darabi K, Makar RS. Acute hemolysis of transfused A2 red cells by an auto-HI antibody. Transfusion 2008;48:964–8.
- Irani MS, Richards C. Hemolytic transfusion reaction due to anti-IH. Transfusion 2011;51:2676–8.
- Ibanez C, Habibi A, Mekontso-Dessap A, et al. Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients. Transfusion 2016;56:1828–33.
- Read S, Witeoak E, Benjamin R. Unusual IH-like antibody implicated in delayed hemolytic transfusion reaction (abstract). Transfusion 2003;43(Suppl):101a.
- Boonyasampant M, Weitz IC, Kay B, Boonchalermvichian C, Liebman HA, Shulman I A. Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab. Transfusion 2015;55:2398–403.
- Win N, Yeghen T, Needs M, Chen FE, Okpala I. Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease. Hematology 2004;9:433–6.
- Algiraigri AH, Wright NA, Kassam A. Hydroxyurea for β-Thalassemia Major: A Meta-Analysis. Blood 2014;124:4894.
- Musiałek MW, Rybaczek D. Hydroxyurea—the good, the bad and the ugly. Genes 2021;12:1096. doi:10.3390/genes12071096.
- Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 2008;32:956–73.
- Zhang L, Zong Z-Y, Liu Y-B, Ye H, Ly X-J. PCR versus serology for diagnosing Mycoplasma pneumoniae infection: a systematic review & meta-analysis. Indian J Med Res 2011; 134:270–80.
- Loens K, Goossens H, Leven M. Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods. Eur J Clin Microbiol Infect Dis 2010;29:1055–69.
- Hamblin T. Management of cold agglutination syndrome. Transfus Sci 2000;22:121–4.
- Petz LD. Cold antibody autoimmune hemolytic anemias. Blood Rev 2008;22:1–15.
- Packman CH. The clinical pictures of autoimmune hemolytic anemia. Transfus Med Hemother 2015;42:317–24. doi:10.1159/000440656.
- Berentsen S, Fattizzo B, Barcellini W. The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket? Front Immunol 2023;14:1180509. doi:10.3389/fimmu.2023.1180509.